NCT03347318 2026-03-19
PROFILING
Fondazione del Piemonte per l'Oncologia
Active not recruiting
Clinical Trials
4 trialsNCT07407985 2026-02-12
GK01IIT-TZ03
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Active not recruiting
NCT02498912 2025-07-31
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT05522582 2024-10-26
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
Yancheng First People's Hospital
Phase 2 Active not recruiting